Senior insider sale
Chief Executive Officer at DEFINIUM THERAPEUTICS, INC. — senior position signals high conviction
$1.95M
48.23K shares
What this filing means
BARROW ROBERT plans to sell 48.23K shares of DEFINIUM THERAPEUTICS, INC. valued at approximately $1.95M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/3/2026ACC: 0001950047-26-009064
DirectorOfficer· Chief Executive Officer
Since Jan 2022
48.23K
Shares to sell
$1.95M
Approx. market value
19.02K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Performance Stock Units
Services Rendered
9/3/2026
19.02KTotal acquired19.02K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/3/2026 | Performance Stock Units Services Rendered | 19.02K | — |
| Total | 19.02K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
29.21K
Market value
$1.23M
6/25/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
19.02K
Market value
$718.1K
9/3/2026
Total
Units
48.23K
Value
$1.95M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/25/2026 | 29.21K | $1.23M | — | Completed |
| Planned — Approximate Date | ||||
9/3/2026 | 19.02K | $718.1K | NASDAQ | Planned |
| Total | 48.23K | $1.95M | ||